Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-01

Clinical Trial Update: CBD for the Treatment of Alcohol Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 study assessing cannabidiol (CBD) for alcohol use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (CBD) (cannabidiol)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Alcohol Use Disorder | Phase 2 | Status: COMPLETED